These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20134397)

  • 1. NOD-scid IL2rgamma(null) mouse model of human skin transplantation and allograft rejection.
    Racki WJ; Covassin L; Brehm M; Pino S; Ignotz R; Dunn R; Laning J; Graves SK; Rossini AA; Shultz LD; Greiner DL
    Transplantation; 2010 Mar; 89(5):527-36. PubMed ID: 20134397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
    Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
    Murray AG; Schechner JS; Epperson DE; Sultan P; McNiff JM; Hughes CC; Lorber MI; Askenase PW; Pober JS
    Am J Pathol; 1998 Aug; 153(2):627-38. PubMed ID: 9708821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.
    Ishikawa F; Yasukawa M; Lyons B; Yoshida S; Miyamoto T; Yoshimoto G; Watanabe T; Akashi K; Shultz LD; Harada M
    Blood; 2005 Sep; 106(5):1565-73. PubMed ID: 15920010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.
    Covassin L; Laning J; Abdi R; Langevin DL; Phillips NE; Shultz LD; Brehm MA
    Clin Exp Immunol; 2011 Nov; 166(2):269-80. PubMed ID: 21985373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
    Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
    Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a humanized mouse model to study the role of macrophages in allograft injury.
    Kirkiles-Smith NC; Harding MJ; Shepherd BR; Fader SA; Yi T; Wang Y; McNiff JM; Snyder EL; Lorber MI; Tellides G; Pober JS
    Transplantation; 2009 Jan; 87(2):189-97. PubMed ID: 19155972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
    Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
    Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
    Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP
    Clin Cancer Res; 2009 May; 15(10):3277-86. PubMed ID: 19447870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.
    Bernstein JM; Brooks SP; Lehman HK; Pope L; Sands A; Shultz LD; Bankert RB
    Ann Otol Rhinol Laryngol; 2009 Dec; 118(12):866-75. PubMed ID: 20112521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human cord blood engraftment between immunocompromised mouse strains.
    McDermott SP; Eppert K; Lechman ER; Doedens M; Dick JE
    Blood; 2010 Jul; 116(2):193-200. PubMed ID: 20404133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
    Brehm MA; Kenney LL; Wiles MV; Low BE; Tisch RM; Burzenski L; Mueller C; Greiner DL; Shultz LD
    FASEB J; 2019 Mar; 33(3):3137-3151. PubMed ID: 30383447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
    Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
    Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin allografts--lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model.
    Galkowska H; Olszewski WL; Moscicka M; Cybulska E; Ziolkowska A; Wojewodzka U; Mijal J
    Ann Transplant; 1999; 4(3-4):5-10. PubMed ID: 10853773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
    Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
    J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G; Morgan JR
    Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.